Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 11:37:04 +0200Fri, 14 Jun 2024 11:30:00 +0200Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 16, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/kisqaliHuman medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 16, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/kisqaliFri, 14 Jun 2024 11:30:00 +0200Human medicineKisqali : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500233998_en.pdfKisqali : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500233998_en.pdfThu, 31 Aug 2017 02:00:00 +0200Human medicine